BPIQ Blog

Feb 19, 20211 min read

Free Biopharma Daily Stock Updates - 02/19/21

$XBI $159.07 +2% 📈 Want to access our searchable database of catalysts and more? Get access to BiopharmIQ for 30 days free, no credit...

Feb 18, 20211 min read

Free Biopharma Daily Stock Updates - 02/18/21

$XBI $156.54 -3% 📉 Want to access our searchable database of catalysts and companies? Get access to BiopharmIQ for 30 days free, no...

Feb 17, 20211 min read

FREE Biopharma Daily Stock Updates - 02/17/21

Want to access our searchable database of catalysts and companies? Get access to BiopharmIQ for 30 days free, no credit card required....

Feb 16, 20211 min read

FREE Biopharma Daily Stock Updates - 02/16/21

Want to access our searchable database of catalysts and companies? Get access to BiopharmIQ for 30 days free, no credit card required....

Feb 10, 20211 min read

Biopharma Daily Stock Updates - 02/10/21

$XBI $168.01 -2% 📉 PIPELINE: $PLX -11% Phase 3 data from BRIDGE trial of pegunigalsidase alfa (PRX–102) treating Fabry Disease. source...

Feb 9, 20211 min read

Biopharma Daily Stock Updates - 02/09/21

$XBI $171.86 -1% 📉 PIPELINE: $HTBX +50% Positive interim survival data from ongoing HS-110 ph 2 NSCLC trial. source $RMTI +30%...

Feb 8, 20211 min read

Biopharma Daily Stock Updates - 02/08/21

$XBI $173.99 +4% 📈 COVID: $EIGR +12% Phase 2 covid data published in Lancet Respiratory Medicine journal. source PIPELINE: SRNE +18%...

Feb 5, 20211 min read

Biopharma Daily Stock Updates - 02/05/21

$XBI $166.78 +2% 📈 PIPELINE: $TGTX +12% UKINIQ FDA approval for adult patients with relapsed or refractory marginal zone lymphoma after...

Feb 4, 20211 min read

Biopharma Daily Stock Updates - 02/04/21

$XBI $162.77 +1% COVID: $DVAX +2% Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine...

Feb 3, 20211 min read

Biopharma Daily Stock Updates - 02/03/21

Get BPIQ Pro and gain access to our database of over ~300 companies and ~1,200 drug assets. Featuring a fully searchable catalyst...

Feb 2, 20211 min read

Biopharma Daily Stock Updates - 02/02/21

$XBI $163.24 +2% 📈 PIPELINE: $VYGR +6% $NBIX terminated collaboration $SAVA +141% Positive interim data $DRRX +18% FDA approval of...

Feb 1, 20212 min read

Biopharma Daily Stock Updates - 02/01/21

$XBI $159.62 +4.41% 📈 COVID: $AMPE +15% - AMPIO ANNOUNCES EARLY POSITIVE DATA IN PHASE 1 TRIAL OF INHALED AMPION IN COVID-19 RESPIRATORY...

Jan 29, 20211 min read

Biopharma Daily Stock Updates - 01/29/21

$XBI $152.88 (+0.82%) 📈 COVID: $CYDY (+8.82%) - Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compassionate Special...

Jan 28, 20211 min read

Biopharma Daily Stock Updates - 01/28/21

$XBI $151.64 (-0.43%) COVID: $NVAX (+2.16%) - Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial $RDHL (+1.38%) -...

Jan 27, 20211 min read

Biopharma Daily Stock Updates - 01/27/21

$XBI $152.30 (-1.35%) 📉 COVID: $BNTX (-0.30%) & $PFE (-2.87%) - In Vitro Studies Demonstrate Pfizer and BioNTech COVID-19 Vaccine...

Jan 26, 20211 min read

Biopharma Daily Stock Updates - 01/26/21

$XBI $154.38 (-1.76%) 📉 COVID: $MRNA (+3.30%) - Moderna Provides U.S. COVID-19 Vaccine Supply Update PIPELINE: $AMRN (-1.06%) - AMARIN...

Jan 25, 20211 min read

Biopharma Daily Stock Updates - 01/25/21

$XBI $157.14 (+3.00%) 📈 COVID: $MRNA (+12.20%) - Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First...

Jan 22, 20211 min read

Biopharma Daily Stock Updates - 01/22/21

$XBI $152.56 (+1.18%) 📈 COVID: $AMPE (+16.13%) - AMPIO PHARMACEUTICALS ONGOING PHASE I CLINICAL TRIAL FOR INHALATION TREATMENT OF...

Jan 21, 20211 min read

Biopharma Daily Stock Updates - 01/21/21

$XBI $150.78 (-2.17%) 📉 COVID: $VBIV (-6.53%) - VBI Vaccines Announces Progress of Coronavirus Vaccine Program...

Jan 20, 20212 min read

Biopharma Daily Stock Updates - 01/20/21

$XBI $154.13 (-0.09%) 📉 COVID: $PFE (-0.65%) & $BNTX (-1.40%) - Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine...

Jump start your biotech due diligence

Get started →

Our platform helps you uncover your next biotech investment opportunity